English
繁體中文
简体中文
Scientists have long debated a critical question: did life learn to breathe oxygen before or after the Great Oxidation Event about 2.4 billion years ago, when atmospheric oxygen first began to accumulate? A new CUHK study now provides strong evidence that it happened much earlier, hundreds of millions of years before the event. Using an AI model, CUHK researchers found that long before oxygen began accumulating in Earth's atmosphere, tiny microbial pioneers were already experimenting with breathing it, thriving inside microscopic oxygen-rich pockets. This discovery not only rewrites the history of life on Earth but also has profound implications in an era of climate change.
For generations, a heart attack has been seen as an irreversible decline. But a groundbreaking discovery by CUHK researchers may now be poised to change that. They have identified a hidden regenerative “switch” within the human immune system. Flipping it back on could reawaken the heart's dormant ability to heal itself—a power it once briefly held in infancy—turning a heart attack from a point of no return into a new beginning. This discovery doesn't just challenge a long-held medical belief; it opens an entirely new frontier in repairing damaged hearts.
Imagine being able to peer inside the human brain with unprecedented clarity—not through psychic vision, but through advanced technology. This is the promise of today’s neuroimaging breakthroughs. At CUHK, an AI-assisted, next-generation system is taking shape, capable of providing real-time, highly detailed brain maps with exceptional accuracy. This powerful new tool is set to equip neurosurgeons in their fight against some of the deadliest of all diseases.
Cancer’s toughest strongholds – solid tumours like those in the lung, liver, and pancreas – have long outwitted modern medicine. But what if the key to defeating them was already inside us – just hidden hero in plain sight? Using powerful AI to peer into cancer at single-cell resolution, CUHK researchers have discovered a previously unknown immune cell that can naturally hunt down and destroy solid tumours from within – a feat where conventional treatments fail. Even more remarkably, the team has developed a way to manufacture these “Super” immune cells from a patient’s blood, potentially opening the door to a brave new world of safe, fast-acting, cancer-bashing immunotherapy.
CUHK continues to demonstrate exceptional research excellence on the global stage. Leading individual honours is Professor Kwan Mei-po, who has been elected a Fellow of The World Academy of Sciences, alongside 17 CUHK scholars recognised as Highly Cited Researchers 2025. The University's innovative impact was further cemented by six awards at the influential iENA exhibition in Germany, capped off by a dominant performance at the Asia Exhibition of Innovations and Inventions Hong Kong, where CUHK emerged as one of the biggest winners with 10 awards.